Page last updated: 2024-12-11

hercynine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

hercynine: structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID5459798
CHEBI ID15781
SCHEMBL ID1331027
MeSH IDM0051400

Synonyms (23)

Synonym
unii-m8mwm6k25v
m8mwm6k25v ,
1h-imidazole-4-ethanaminium, alpha-carboxy-n,n,n-trimethyl-, hydroxide, inner salt, (s)-
n(alpha),n(alpha),n(alpha)-trimethyl-l-histidine
(2s)-3-(1h-imidazol-4-yl)-2-(trimethylammonio)propanoate
CHEBI:15781
(s)-alpha-carboxy-n,n,n-trimethyl-1h-imidazole-4-ethanaminium hydroxide, inner salt
nalpha,nalpha,nalpha-trimethyl-l-histidine
hercynine
534-30-5
(2s)-3-(1h-imidazol-5-yl)-2-(trimethylazaniumyl)propanoate
SCHEMBL1331027
l-(1-carboxy-2-imidazol-4-ylethyl)trimethyl ammonium hydroxide inner salt
histidine-betaine
hercynine [mi]
(.alpha.s)-.alpha.-carboxy-n,n,n-trimethyl-1h-imidazole-4-ethanaminium inner salt
1h-imidazole-4-ethanaminium, .alpha.-carboxy-n,n,n-trimethyl-, inner salt, (.alpha.s)-
.alpha.-n,n,n-trimethylhistidine
Q27895009
BS-47341
(s)-3-(1h-imidazol-5-yl)-2-(trimethylammonio)propanoate
1h-imidazole-4-ethanaminium, a-carboxy-n,n,n-trimethyl-, inner salt,(as)-
F72348

Research Excerpts

[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (2)

ClassDescription
N(alpha)-methyl-L-histidinesA N-methyl-L-alpha-amino acid that is L-histidine in which at least one of the amino hydrogens has been replaced by a methyl group.
amino-acid betaineAny amino acid-derived zwitterion - such as glycine betaine (N,N,N-trimethylammonioacetate) - in which the ammonium nitrogen carries methyl substituents and bears no hydrogen atoms.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (2)

PathwayProteinsCompounds
ergothioneine biosynthesis I (bacteria)522
ergothioneine biosynthesis II (fungi)215

Research

Studies (14)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (14.29)18.7374
1990's0 (0.00)18.2507
2000's1 (7.14)29.6817
2010's8 (57.14)24.3611
2020's3 (21.43)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 28.67

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index28.67 (24.57)
Research Supply Index2.71 (2.92)
Research Growth Index5.59 (4.65)
Search Engine Demand Index31.58 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (28.67)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other14 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]